全人的治療 (a whole person treatment) Holistic medicine

Teresa Fuller M.D., Ph.D., Holistic Pediatrician, Joins National Integrated Health Associates  National Integrated Health Associates (NIHA) is pleased to announce Teresa Fuller M.D., Ph.D., Holistic Pediatrician, as part of the integrative medical team. Dr. Fuller is Board Certified in Pediatrics and Integrative Holistic Medicine. Washington, D.C. (PRWEB) March 04, 2014 National Integrated Health Associates (NIHA) has expanded to include pediatrics as part of the Washington D.C. integrative medical and dental center. Teresa Fuller, M.D., Ph.D., joins NIHA with board certification in both pediatrics and integrative holistic medicine. Dr. Fuller also has a doctorate in physiology and understands the complex metabolic processes of the human body. This powerful combination of the pediatric, holistic and physiology disciplines places Dr. Fuller in a unique position to positively impact the health of children and young adults. In her practice during the last ten years, Dr. Fuller has seen increasing numbers of children suffering from chronic conditions such as ADHD, allergies, chronic pain, autism and even traditionally adult diseases such as type 2 diabetes. Often, medication offers only partial relief while the root cause of these disorders remains undiagnosed. This has prompted her to learn how to identify the root cause of chronic illness, and use a holistic approach to correct underlying nutritional deficiencies and toxic accumulations to restore health.

Caring for the Whole Child  In assessing a patient, the integrative physician will inquire not only about health history and symptoms, but will also ask about diet, exercise, stress, home and school environment, and emotional well-being. A holistic pediatric treatment plan may include a nutrition plan, herbals, detoxification and perhaps antibiotics, designed to correct deficiencies and enhance the natural healing process. Dr. Fuller fully supports parents to make educated, informed, individual health care decisions for their families. Dr. Fuller has authored a book, "Change 1 Thing! A Doctor's 12-Step Guide to Permanent Weight Loss, Disease Prevention and a Lifetime of Incredible Health". She says, "I love to empower people with information to help them improve their health, which was the stimulus behind writing my book."The addition of a holistic pediatrician at NIHA fulfills a tremendous need in the Washington, D.C. area to offer holistic integrative medical care to babies, children and young adults.Dr. Fuller is now accepting patients for well baby care, children and young adults to age 26.

About National Integrated Health Associates National Integrated Health Associates, NIHA, is a leading integrative medicine and dental center serving the Washington D.C., Maryland, and Virginia metropolitan area. Integrative physicians, biological dentists and a team of holistic practitioners blend the best of traditional medicine and integrative medical therapies to help the body heal and achieve optimum wellness. http://www.nihadc.com

 

(早洩) 歐盟上市Lidocaine+Prilocaine 噴劑 /美國將成為一藥物

早洩噴劑 助快槍俠展5倍雄風 【2013/9/24 01:15】 〔中央社〕壯陽藥「威而鋼」發明人魏里（Mike Wyllie）研發出治療早洩噴劑Tempe，試驗顯示此噴劑能讓男性提高5倍持久力。歐盟藥品管理局認定此藥物安全有效，可望於明年初上市。英國「每日郵報」（Daily Mail）報導，威而鋼（Viagra）發明人魏里博士宣稱，這種新藥可協助更多人享受魚水之歡。90年代研發出威而鋼團隊成員之一的魏里正準備推出治療早洩噴劑Tempe。歐洲藥品管理局（EMA）認定，Tempe安全有效，最早可望於明年初上市。報導說，每4名男子平均至少1人有早洩困擾，較威而鋼治療的勃起困難更常見。在臨床實驗中，於嘿咻前使用此噴劑的男子，持久力平均延長5倍。做愛時間延長，也讓女性受益，男女兩性都對性生活表達更大滿意度。早洩可能打擊男性自尊，讓建立和維持關係變得困難，在更糟情況下，它可能讓伴侶無法懷孕。目前市面上只有一種藥物專供治療早洩，但價格昂貴，且在英國境內無法普遍取得。早洩的確實原因不明，據信與過度敏感有關。Tempe噴劑內含兩種低劑量麻醉藥，可協助男人提高掌控力。此噴劑約5分鐘就見效，但嘿咻前兩小時使用也管用。如果男性每個月行房5到6次，袖珍型1小罐可使用長達1年。但一些試用此噴劑的男子，出現包括灼熱感和頭痛等副作用。也有人擔心使用此藥物充當「應急之道」，將會妨礙伴侶面對引發早洩的真正問題，諸如壓力、焦慮和關係緊張等。

What Is TEMPE Spray? TEMPE (Topical eutectic-like mixture for premature ejaculation) now approved in Europe with the name of "Lidocaine Prilocaine Plethora" is a rapidly acting spray formulation of two local anaesthetics (three metered doses of the spray applied to the glans of the penis delivering 22.5mg lidocaine and 7.5mg prilocaine) for the treatment of premature ejaculation (PE) and developed by Plethora Solutions Ltd, London. It is spritzed onto the tip of the penis few minutes (<5 minutes) before sex and does not require condom use. Lidocaine Prilocaine Plethora spray (also known as TEMPE or PSD502) delivers a localised application of anaesthetic and is rapidly absorbed by the non- keratinised skin of the glans penis.The anaesthetic in Lidocaine Prilocaine Plethora spray doesn't penetrate intact or fully keratinised skin and can be easily wiped off with a damp cloth in order to minimise transference to the sexual partner. Lidocaine Prilocaine Plethora spray was also well tolerated by the female partners, with reports of 3.9% vulvovaginal discomfort or burning sensation caused discontinuation of treatment in 0.3% of subjects. Studies have demonstrated that the onset of action of Lidocaine Prilocaine Plethora spray is within minutes (<5) and that the benefit lasts for at least 2 hours. The product will be commercialized in the mid-to late-2014, across all 27 member states in Europe (UK, Germany, Spain, France, Italy, Netherlands, Portugal, Sweden, and so on). Plethora Spray has met all co-primary endpoints with the USA-FDA Phase III study: The intra-vaginal ejaculation latency time (IELT) was increased at least six-fold with Tempe Spray when compared to baseline. There was a 5 point difference between Tempe Spray and placebo in the Index of Premature Ejaculation (IPE) domains for ejaculatory control and sexual satisfaction, where a 2 point difference is considered clinically significant. IPE domain for Distress was a 2.5-point difference between Tempe Spray and placebo, where a 2 point difference is considered clinically significant. And partner satisfaction, as a secondary endpoint, was also found considerably greater with Tempe Spray than placebo. Plethora Spray was well tolerated and only a very low incidence of mild penile numbing (<3%) was observed. Plethora Spray Phase III recruitment programme in the USA is now completed for the treatment of premature ejaculation. Plethora Spray would be the first prescription treatment in the United States for premature ejaculation, upon FDA approval. In Europe, a phase III study data show on average, men who got the spray lasted 6.3 times longer than those who got the placebo.  Results of a phase III clinical trials with 300 heterosexual men with premature ejaculation shows that 90% of the men in the treatment with TEMPE spray were able to delay ejaculation for more than one minute following vaginal penetration, 74% of men last more than two minutes before ejaculation and 62% of men with TEMPE spray said their orgasms were 'good' or 'very good' after three months. The men had an average age of 35. On November 19, 2013, the European Commission has granted marketing authorisation under the name 'Prilocaine Lidocaine Plethora', to treat primary premature ejaculation in adult men.

FDA 禁ketoconazole口服一線用藥

傷肝腎！美禁口服抗黴菌藥　台灣一年20萬人使用 鉅亨網新聞中心　(來源：NOWnews)　2013-09-17 13:08:03　 記者陳鈞凱／台北報導 台灣氣候潮溼，不少人飽受股癬、汗斑、香港腳等黴菌感染困擾，療效快速，許多皮膚科醫師都愛用的「ketoconazole」藥品，卻因為可能潛藏致命的肝腎損傷風險，日前遭美國FDA禁止作為治療任何黴菌感染的第一線用藥。衛生福利部統計，國內每年約20萬人使用該藥，已發函提醒醫師小心，要求藥廠提安全評估。美國食品藥物管理局（FDA）日前是針對ketoconazole成分的口服劑型藥品潛在可能致命的肝腎損傷風險，要求限縮該藥品使用，不可作為治療任何黴菌感染的第一線用藥，只可用於其他抗黴菌藥品治療無效時或無法耐受的特定黴菌感染。不過美國FDA的警訊只針對ketoconazole的口服劑型，至於塗抹的藥膏、凝膠、洗髮精等劑型，並沒有風險，民眾不需擔心，可以安心使用。衛生福利部食品藥物管理署藥品組簡任技正戴雪詠表示，ketoconazole是國內皮膚科醫師經常使用的藥物，根據健保資料統計，每一年約有20萬人使用這類藥物來治療黴菌感染。戴雪詠強調，ketoconazole口服劑型的副作用，可能傷害肝腎，醫界過去就了解，但為了確保民眾用藥安全，食藥署已經再度發出風險溝通表給各醫療院所以及皮膚科、家醫科、內科等3大醫學會，提醒醫師應該謹慎使用ketoconazole類藥物；另外，也要求藥廠完成並提出藥品安全評估報告。Ketoconazole問世已久，是醫師臨床愛用的老藥！皮膚科醫師趙昭明表示，幾乎各大醫療院所都用來治療股癬、汗斑、灰指甲、香港腳等黴菌感染；Ketoconazole分為口服以及外用兩劑型，有傷肝腎疑慮的主要是口服劑型，因為必須經由肝臟代謝。趙昭明說，黴菌感染依嚴重程度，有表淺感染及深層感染兩種，前者以擦藥為主，後者像頑固型香港腳、汗斑、女性會陰部白色念球菌感染等，若擦藥治療效果不好，醫師為求療效，往往還會使用口服藥錠，雙管齊下。Ｂ肝、Ｃ肝帶原者或肝功能異常，趙昭明建議，最好主動告知醫師，如果已經在吃ketoconazole口服藥的病患有疑慮，也不要隨意停藥，應先與醫師討論，且用藥期間應避免喝酒，一旦出現異常疲勞、尿液顏色加深、糞便變白或黃疸症狀，應立即就醫檢查。藥害救濟基金會也提醒，國內目前核准ketoconazole口服藥的適應症僅有「髮癬、汗斑」，提醒醫師開立藥物之前，應謹慎評估風險效益，治療期間也需定期追蹤患者肝功能變化。

 

熬夜 非等同 “爆肝”

爆肝不是「熬夜」的錯　「熬夜」是無辜的！日期：2013.09.25 ◎ uho新聞部 （優活健康網記者陳承璋／綜合報導）喔！天啊，我又要爆肝了，連續好幾天熬夜趕案子，趕都趕不完。相信這是許多上班族的爆肝心聲，但是，熬夜真的會傷肝嗎？其實，熬夜與肝臟病不完全相關，若民眾把肝功能不好或肝炎歸咎在長期熬夜上，那可就大錯特錯！

熬夜等於肝不好？大錯特錯！預防醫學陳皇光醫師指出，就現代醫學的觀點，肝臟24小時都在執行消化、解毒及排除廢物的工作，並不只有特定在半夜運作。長期勞累或熬夜並不會直接影響肝臟功能，將肝功能不好歸因為過度疲憊或熬夜工作是倒因為果的錯誤觀念。一般常見的肝炎，主要原因可分為4種，酗酒、肥胖、藥物 （止痛藥、降膽固醇藥物、抗結核藥物等）、病毒 （B、C型肝炎）。他解釋，若是GOT、GPT值異常的話，代表當時肝臟有發炎現象，但不能完全歸諸於熬夜、工作勞累、壓力大，但值得注意的是，只做肝功能抽血檢查，並無法得知是否有B或C肝帶原、肝硬化及癌症等狀況。

檢查肝好不好　只需做GOT、GPT檢測？而肝炎的病因中，危害最大的是B、C型肝炎帶原，根據健保局統計，肝癌患者有八成以上為B型肝炎帶原者，而無B型肝炎帶原之肝癌患者，一半以上則有C型肝炎感染者，也就是說台灣的肝癌患者九成與B、C 型肝炎有關，自然演變成所謂「慢性肝炎→肝硬化→肝癌」三部曲。對此，陳皇光建議初次健康檢查，一定要檢查肝炎病毒指標，若沒有B 、C 型肝炎帶原，又沒有酗酒、肥胖及服藥問題，原則上肝臟幾乎不太可能出現大問題。若想預防肝癌上身，應該先作B 、C 型肝炎的篩檢，了解自己是否有帶原，若沒有B 型肝炎抗體者，應考慮接受B型肝炎疫苗注射，以避免被傳染。若為40歲以上的慢性肝炎帶原者、肝硬化及有肝癌家族病史等肝癌高危險群，應定期接受甲種胎兒蛋白及腹部超音波追蹤檢查，以便能早期發現早期治療。

中央大學: 課程設計從「產業端」回推「課程端」

中大成立生醫理工學院　院長從哈佛挖 2014年01月13日13:35 【陳威廷／台北報導】為培育跨領域人才，促進台灣生醫產業發展，中央大學整合生命科學系、認知與神經科學研究所、系統生物與生物資訊研究所、生物醫學工程研究所和跨領域轉譯醫學研究所等1系4所，成立生醫理工學院，是該校第8個學院，並延攬美國哈佛大學醫學院教授彭仲康擔任第1任院長，預計在今年8月正式招生。中大校長周景揚表示，醫療照護產業是一個跨領域且整合度相當高的產業，考量到產業的整體需求，生醫理工學院課程設計從「產業端」回推到「課程端」，希望培養出來的人才，能適時地與產業結合，支持產業發展。彭仲康說，生醫理工學院發展有兩大方向，一是開發「低成本」的創新醫療技術，二是推動「預防醫療」的創新技術。他表示，除與國內各大學醫療單位合作，還將與神達電腦、宏達電、台達電、宏碁電腦、聯發科、鴻海、神隆和順天堂等知名企業合作，還要與美國哈佛大學醫學院、英國倫敦大學建立關係，與世界一流研究接軌。今年54歲的彭仲康說，他當年就讀台大地質系2年後覺得與興趣不符，轉學考上交大電子物理系，並接受中研院前院長吳大猷指導，開啟對基礎科學研究的興趣，碩士班考取清大物理所，最後在美國波士頓大學取得物理博士學位。他說，博士班畢業前想到哈佛大學醫學院做博士後研究，但另有一份工作薪水更高的工作也等他點頭，結果有天他與妻子在餐廳吃飯，餐後的幸運餅乾內的紙條居然寫著：「你適合從事醫學研究」，他笑著跟老婆說：「這是上天的旨意！」便到哈佛任職。